Shopping News / Articles
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Autologous Cell Therapy Market
1+ hour, 34+ min ago (56+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....
Cell therapy weekly: world's first B-cell therapy administered to pediatric patient
2+ hour, 51+ min ago (462+ words) Reg Med Net is part of Taylor & Francis Group. The therapy aims to overcome the limitations of current enzyme replacement therapy infusions and address safety concerns associated with stem cell therapy. ISP-001 utilizes the patient's own B cells to produce…...
Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda
2+ hour, 10+ min ago (271+ words) New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included Gene therapy for sickle cell disease (SCD) could be cost-effective in Uganda " but only if prices are dramatically reduced and…...
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
1+ hour, 7+ min ago (229+ words) Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Novartis is hiring! Find open positions, learn more about our strategy and culture, and…...
New formulation of Astellas Pharma Korea's Xtandi receives national health insurance coverage
4+ hour, 31+ min ago (287+ words) Astellas Pharma Korea said Thursday that a tablet formulation of its prostate cancer treatment, Xtandi (enzalutamide), has been newly listed for national health insurance coverage from April 1. The newly covered Xtandi tablets are available in 40mg and 80mg doses. The 40mg tablet has…...
Ro is now selling Foundayo, a second daily oral GLP-1 alternative to injectable therapies
1+ hour, 7+ min ago (189+ words) Ro adds Lilly's Foundayo to its weight-loss options days after FDA approval. Ro is expanding its weight-loss offering with the addition of Eli Lilly's newly approved oral GLP-1, Foundayo (orforglipron), giving patients a second daily pill alternative to injectable therapies…...
How to Use Real-World Data to Improve Drug Development, Starting with the Patient Journey
52+ min ago (157+ words) Med City News A significant number of non-small cell lung cancer patients (NSCLC) patients miss out on optimal care due to gaps in biomarker testing, socioeconomic barriers, and incomplete patient journey data. A new e Book from Purple Lab and…...
Cell Therapy and Gene Therapy CDMO Market Is Booming Rapidly with Strong Demand By 2033| Lonza " Wu Xi App Tec " Catalent
36+ min ago (71+ words) Cell Therapy and Gene Therapy CDMO Market Is Booming Rapidly with'open PR. com Cell Therapy and Gene Therapy CDMO Market Is Booming Rapidly with Strong Demand By 2033| Lonza " Wu Xi App Tec " Catalent Press release from: Coherent Market Insights Permanent…...
Esther Formula Announces U. S. Debut of K-Wellness Liposomal Glutathione Strips
11+ hour, 31+ min ago (427+ words) Financial Content Esther Formula Announces U. S. Debut of K-Wellness Liposomal Glutathione Strips United States, April 9, 2026 -- Esther Formula, a Korean-born K-wellness brand with a U. S. subsidiary, announced the official Esther Formula US Launch, marking its debut in the United States following strong popularity…...
Guest column: More than just a flu shot " the unexpected power of vaccines
52+ min ago (408+ words) By: Dr. Mehdi Aloosh What if your flu shot did more than protect you from the flu? What if it also lowered your risk of a heart attack or stroke? What if the shingles vaccine helped protect you from dementia,…...
Shopping
Please enter a search for detailed shopping results.